A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
PHASE3CompletedINTERVENTIONAL
Enrollment
811
Participants
Timeline
Start Date
February 29, 2000
Study Completion Date
February 28, 2005
Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG
risperidone
All Listed Sponsors
lead
Janssen, LP
INDUSTRY
NCT00558298 - A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder. | Biotech Hunter | Biotech Hunter